How is the Iceland Pharmaceutical Market segmented by drug class?
The Iceland Pharmaceutical Market is segmented by drug class, providing a clear picture of the industry’s focus and growth areas. The primary segments include cardiovascular drugs, central nervous system (CNS) drugs, and anti-infectives. The cardiovascular drugs segment is particularly dominant, driven by the high prevalence of cardiovascular diseases in the country and a well-established infrastructure for diagnosis and treatment. This segment is characterized by a strong demand for a variety of products, from beta-blockers to statins, that are essential for enabling a safe and effective therapeutic outcome. For a detailed breakdown of the market by drug class, you can check out the Iceland Pharmaceutical Market segmentation report.
The anti-infectives and central nervous system drugs segments are also a significant and growing part of the market. The anti-infectives segment is characterized by a high demand for a variety of…
